Welcome to visit Zhongnan Medical Journal Press Series journal website!

The effect of TRIM7 on lipid accumulation in foam cells in atherosclerosis

Published on Apr. 30, 2026Total Views: 10 timesTotal Downloads: 2 timesDownloadMobile

Author: ZHAO Yilin HOU Bowen CAI Zeming YANG Yi ZHU Lihua

Affiliation: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China

Keywords: Foam cells E3 ubiquitin-protein ligase TRIM7 Atherosclerosis

DOI: 10.12173/j.issn.1004-5511.202502052

Reference: Zhao YL, Hou BW, Cai ZM, et al. The effect of TRIM7 on lipid accumulation in foam cells in atherosclerosis[J]. Yixue Xinzhi Zazhi, 2026, 36(4): 421-427. DOI: 10.12173/j.issn.1004-5511.202502052. [Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective  To investigate the effect of TRIM7, an E3 ubiquitin protein ligase, on lipid accumulation in foam cells derived from mouse bone marrow-derived macrophages (BMDMs) and its mechanism.

Methods  Western blot and qRT-PCR were used to detect the expression changes of TRIM7 in BMDMs stimulated by oxidized low-density lipoprotein. Construct TRIM7 knockout BMDMs and TRIM7 overexpression THP-1 cell lines, and analyze the effect of TRIM7 on lipid metabolism of BMDMs through qRT-PCR, oil red staining, and total cholesterol content detection. Western blot was used to detect the phosphorylation levels of MAPK signaling pathway proteins in BMDMs after TRIM7 knockout. Immunoprecipitation detection of the interaction between TRIM7 and the upstream kinase TAK1 in the MAPK pathway.

Results  TRIM7 interacted directly with TAK1, TRIM7 knockout could enhance the phosphorylation activity of MAPK signaling pathway protein, up regulate the expression of CD36 and MSR1 and inhibit the expression of ABCA1, increase cholesterol uptake and reduce lipid excretion, and ultimately promote the formation of foam cells.

Conclusion  TRIM7 negatively regulates lipid accumulation in foam cells by inhibiting MAPK signaling pathway and scavenger receptor expression by directly binding to TAK1, which provides a potential new target for the treatment of atherosclerosis.

Full-text
Please download the PDF version to read the full text: download
References

1. Bentzon JF, Otsuka F, Virmani R, et al.Mechanisms of plaque formation and rupture[J]. Circ Res, 2014, 114(12): 1852-1866.

2. Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study[J]. J Am Coll Cardiol, 2020, 76(25): 2982-3021.

3. Fan J, Watanabe T. Atherosclerosis: known and unknown[J]. Pathol Int, 2022, 72(3): 151-160.

4. Mitra S, Goyal T, Mehta JL. Oxidized LDL, LOX-1 and atherosclerosis[J]. Cardiovasc Drugs Ther, 2011, 25(5): 419-429.

5. Gui Y, Zheng H, Cao RY. Foam cells in atherosclerosis: novel insights into its origins, consequences, and molecular mechanisms[J]. Front Cardiovasc Med, 2022, 9: 845942.

6. Uthirapathy S, Ahmed AT, Jawad M, et al. Tripartite motif (TRIM) proteins roles in the regulation of immune system responses: focus on autoimmune diseases[J]. Exp Cell Res, 2025, 444(2): 114379.

7. Xu YR, Lei CQ. TAK1-TABs complex: a central signalosome in inflammatory responses[J]. Front Immunol, 2021, 11: 608976.

8. Moore KJ, Koplev S, Fisher EA, et al. Macrophage trafficking, inflammatory resolution, and genomics in atherosclerosis: JACC macrophage in CVD series (Part 2)[J]. J Am Coll Cardiol, 2018, 72(18): 2181-2197.

9. Jiang H, Zhou Y, Nabavi SM, et al. Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis[J]. Front Cardiovasc Med, 2022, 9: 925923.

10. Lu M, Zhu X, Yang Z, et al. E3 ubiquitin ligase tripartite motif 7 positively regulates the TLR4-mediated immune response via its E3 ligase domain in macrophages[J]. Mol Immunol, 2019, 109: 126-133.

11. Liu Y, Jiang L, Sun X, et al. Interplay between TRIM7 and antiviral immunity[J]. Front Cell Infect Microbiol, 2023, 13: 1256882.

12. Ji R, Gu Y, Zhang J, et al. TRIM7 promotes proliferation and migration of vascular smooth muscle cells in atherosclerosis through activating c-Jun/AP-1[J]. IUBMB Life, 2020, 72(2): 247-258.

13. Shafi S, Codrington R, Gidden LM, et al. Increased expression of phosphorylated forms of heat-shock protein-27 and p38MAPK in macrophage-rich regions of fibro-fatty atherosclerotic lesions in the rabbit[J]. Int J Exp Pathol, 2016, 97(1): 56-65.

14. Seimon TA, Wang Y, Han S, et al. Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice[J]. J Clin Invest, 2009, 119(4): 886-898.

15. Zhao M, Liu Y, Wang X, et al. Activation of the p38 MAP kinase pathway is required for foam cell formation from macrophages exposed to oxidized LDL[J]. APMIS, 2002, 110(6): 458-468.

16. Zhang Q, Liu L, Hu Y, et al. Kv1.3 channel is involved in ox-LDL-induced macrophage inflammation via ERK/NF-κB signaling pathway[J]. Arch Biochem Biophys, 2022, 730: 109394.

17. Fang S, Sun S, Cai H, et al. IRGM/Irgm1 facilitates macrophage apoptosis through ROS generation and MAPK signal transduction: Irgm1+/- mice display increases atherosclerotic plaque stability[J]. Theranostics, 2021, 11(19): 9358-9375.

18. Wang J, Wang J, Zhong J, et al. LRG1 promotes atherosclerosis by inducing macrophage M1-like polarization[J]. Proc Natl Acad Sci U S A, 2024, 121(35): e2405845121.

19. Tareen SU, Emerman M. Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition[J]. Virology, 2011, 409(1): 113-120.

20. Grütter MG, Luban J. TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling[J]. Curr Opin Virol, 2012, 2(2): 142-150.

21. McEwan WA, Tam JC, Watkinson RE, et al. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21[J]. Nat Immunol, 2013, 14(4): 327-336.

22. Wang F, Wang SY, Gu Y, et al. Disturbed shear stress promotes atherosclerosis through TRIM21-regulated MAPK6 degradation and consequent endothelial inflammation[J]. Clin Transl Med, 2025, 15(1): e70168.

23. Zhao J, Cai B, Shao Z, et al. TRIM26 positively regulates the inflammatory immune response through K11-linked ubiquitination of TAB1[J]. Cell Death Differ, 2021, 28(11): 3077-3091.

24. Lu Z, Hao C, Qian H, et al. Tripartite motif 38 attenuates cardiac fibrosis after myocardial infarction by suppressing TAK1 activation via TAB2/3 degradation[J]. iScience, 2022, 25(8): 104780.

Popular Papers